Podcast

Proud to be Here: Declining Rates of Dementia and EPO-Agents for Anemia in Kidney Disease

Subscribe on iTunes

This week, Amol, general internal medicine resident at the University of Toronto, and Fahad, staff internist at St. Michael’s Hospital in Toronto, discuss 2 recent papers:

Is dementia in decline? A study using the well-characterized Framingham cohort found that dementia rates in the last four decades have declined by 20%. Fahad evaluate the quality of this data, and the generalizability of the Framingham cohort to the global population. For a discussion about healthcare costs in dementia, check out our “Cognition Edition” episode.

Existing guidelines recommend using erythropoietin stimulating agents to treat anemia in chronic kidney disease. However, a systematic review and meta analysis found that erythropoietin stimulating agents didn’t improve patients’ health related quality of life. Given the heterogeneity of the studies included, how robust is this result?

Rate us on iTunes and follow us on Twitter @roundstable!

The Papers

1. Incidence of dementia: http://www.nejm.org/doi/full/10.1056/NEJMoa1504327

2. EPO-agents for anemia in kidney disease: http://annals.org/article.aspx?articleid=2491918

Good Stuff

1. IBM and Watson Health: http://www.nytimes.com/2016/02/19/technology/ibm-buys-truven-adding-to-growing-trove-of-patient-data-at-watson-health.html?_r=0

2. Gut microbes in infants: http://www.sciencemag.org/news/2016/02/right-gut-microbes-help-infants-grow?utm_source=sciencemagazine&utm_medium=twitter&utm_campaign=gutbabies-2478

Music Credits (Creative Commons)

In your Robotic Heart – Nicolai Heidlas https://soundcloud.com/nicolai-heidlas/in-your-robotic-heart

Drive – Nicolai Heidlas https://soundcloud.com/nicolai-heidlas/drive-fresh-upbeat-pop-background-music

Vintage Dream – Nicolai Heidlas https://soundcloud.com/nicolai-heidlas/vintage-dream-loungejazzy-background-music

All tracks have been modified for the purposes of this podcast.

Leave a Comment

Your email address will not be published. Required fields are marked *

Republish this article

Republish this article on your website under the creative commons licence.

Learn more